» Articles » PMID: 34202956

Association of MiRNA and MRNA Levels of the Clinical Onset of Multiple Sclerosis Patients

Overview
Journal Biology (Basel)
Publisher MDPI
Specialty Biology
Date 2021 Jul 2
PMID 34202956
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Multiple sclerosis (MS) is a demyelinating disease characterized by chronic inflammation of the central nervous system, in which many factors can act together to influence disease susceptibility and progression. To date, the exact cause of MS is still unclear, but it is believed to result from an abnormal response of the immune system to one or more myelin antigens that develops in genetically susceptible individuals after their exposure to a, as yet undefined, causal agent. In our study, we assessed the effect of microRNAs on the expression level of neuroprotective proteins, including neurotrophins (BDNF and NT4/5), heat shock proteins (HSP70 and HSP27), and sirtuin (SIRT1) in peripheral blood mononuclear cells in the development of multiple sclerosis. The analysis of dysregulation of miRNA levels and the resulting changes in target mRNA/protein expression levels could contribute to a better understanding of the etiology of multiple sclerosis, as well as new alternative methods of diagnosis and treatment of this disease. The aim of this study was to find a link between neurotrophins (BDNF and NT4), SIRT1, heat shock proteins (HSP27 and HSP27), and miRNAs that are involved in the development of multiple sclerosis. The analysis of the selected miRNAs showed a negative correlation of SIRT1 with miR-132 and miR-34a and of BDNF with 132-3p in PBMCs, which suggests that the miRNAs we selected may regulate the expression level of the studied genes.

Citing Articles

A Comprehensive Examination of the Role of Epigenetic Factors in Multiple Sclerosis.

Manna I, De Benedittis S, Porro D Int J Mol Sci. 2024; 25(16).

PMID: 39201606 PMC: 11355011. DOI: 10.3390/ijms25168921.


Role of miRNAs in neurovascular injury and repair.

Sawant H, Sun B, Mcgrady E, Bihl J J Cereb Blood Flow Metab. 2024; 44(10):1693-1708.

PMID: 38726895 PMC: 11494855. DOI: 10.1177/0271678X241254772.


Multiple Sclerosis: Roles of miRNA, lcnRNA, and circRNA and Their Implications in Cellular Pathways.

Cipriano G, Schepici G, Mazzon E, Anchesi I Int J Mol Sci. 2024; 25(4).

PMID: 38396932 PMC: 10889752. DOI: 10.3390/ijms25042255.


Exploring the mRNA and Plasma Protein Levels of BDNF, NT4, SIRT1, HSP27, and HSP70 in Multiple Sclerosis Patients and Healthy Controls.

Sokolowski I, Kucharska-Lusina A, Miller E, Majsterek I Int J Mol Sci. 2023; 24(22).

PMID: 38003363 PMC: 10671202. DOI: 10.3390/ijms242216176.


miRNAs as Predictors of Barrier Integrity.

Bovari-Biri J, Garai K, Banfai K, Csongei V, Pongracz J Biosensors (Basel). 2023; 13(4).

PMID: 37185497 PMC: 10136429. DOI: 10.3390/bios13040422.


References
1.
Latchman D . HSP27 and cell survival in neurones. Int J Hyperthermia. 2005; 21(5):393-402. DOI: 10.1080/02656730400023664. View

2.
Bomprezzi R, Ringner M, Kim S, Bittner M, Khan J, Chen Y . Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease. Hum Mol Genet. 2003; 12(17):2191-9. DOI: 10.1093/hmg/ddg221. View

3.
Hartl F, Hayer-Hartl M . Molecular chaperones in the cytosol: from nascent chain to folded protein. Science. 2002; 295(5561):1852-8. DOI: 10.1126/science.1068408. View

4.
de Faria Jr O, Moore C, Kennedy T, Antel J, Bar-Or A, Dhaunchak A . MicroRNA dysregulation in multiple sclerosis. Front Genet. 2013; 3:311. PMC: 3551282. DOI: 10.3389/fgene.2012.00311. View

5.
Caggiula M, Batocchi A, Frisullo G, Angelucci F, Patanella A, Sancricca C . Neurotrophic factors and clinical recovery in relapsing-remitting multiple sclerosis. Scand J Immunol. 2005; 62(2):176-82. DOI: 10.1111/j.1365-3083.2005.01649.x. View